{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:00:37Z","timestamp":1768705237244,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1245\/s10434-019-08126-9","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T18:10:41Z","timestamp":1577988641000},"page":"1844-1851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?"],"prefix":"10.1245","volume":"27","author":[{"given":"Christina A.","family":"Minami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine S.","family":"Jochelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa L.","family":"Pilewskie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"3","key":"8126_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","volume":"2","author":"PP Rosen","year":"1978","unstructured":"Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW, Jr. Lobular carcinoma in situ of the breast: Detailed analysis of 99 patients with average follow-up of 24\u00a0years. Am J Surg Pathol. 1978;2(3):225\u201351.","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"8126_CR2","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","volume":"22","author":"DL Page","year":"1991","unstructured":"Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22(12):1232\u20139.","journal-title":"Hum Pathol."},{"issue":"3","key":"8126_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146\u201351.","journal-title":"N Engl J Med."},{"issue":"11","key":"8126_CR4","first-page":"2698","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698\u2013708.","journal-title":"A long-term follow-up study. Cancer."},{"issue":"3","key":"8126_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","volume":"136","author":"SB Coopey","year":"2012","unstructured":"Coopey SB, Mazzola E, Buckley JM, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012;136(3):627\u201333.","journal-title":"Breast Cancer Res Treat."},{"issue":"33","key":"8126_CR6","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol. 2015;33(33):3945\u201352.","journal-title":"J Clin Oncol."},{"issue":"4","key":"8126_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","volume":"37","author":"M Hussain","year":"2011","unstructured":"Hussain M, Cunnick GH. Management of lobular carcinoma in situ and atypical lobular hyperplasia of the breast: a review. Eur J Surg Oncol. 2011;37(4):279\u201389.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"8126_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1524-4741.1999.00002.x","volume":"5","author":"ER Frykberg","year":"1999","unstructured":"Frykberg ER. Lobular Carcinoma In Situ of the Breast. Breast J. 1999;5(5):296\u2013303.","journal-title":"Breast J."},{"issue":"61","key":"8126_CR9","doi-asserted-by":"crossref","first-page":"103047","DOI":"10.18632\/oncotarget.21461","volume":"8","author":"P Cheng","year":"2017","unstructured":"Cheng P, Huang Q, Shou J, Hu G, Han M, Huang J. Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study. Oncotarget. 2017;8(61):103047\u201354.","journal-title":"Oncotarget."},{"issue":"3","key":"8126_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1019950918046","volume":"75","author":"CI Li","year":"2002","unstructured":"Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat. 2002;75(3):259\u201368.","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"8126_CR11","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","volume":"20","author":"PR Portschy","year":"2013","unstructured":"Portschy PR, Marmor S, Nzara R, Virnig BA, Tuttle TM. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis. Ann Surg Oncol. 2013;20(10):3240\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"8126_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227\u201336.","journal-title":"N Engl J Med."},{"issue":"6","key":"8126_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/bcr1829","volume":"9","author":"CM Vachon","year":"2007","unstructured":"Vachon CM, van Gils CH, Sellers TA, et al. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007;9(6):217.","journal-title":"Breast Cancer Res."},{"issue":"6","key":"8126_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159\u201369.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"14","key":"8126_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/jnci\/djt124","volume":"105","author":"JA Tice","year":"2013","unstructured":"Tice JA, O\u2019Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013;105(14):1043\u20139.","journal-title":"J Natl Cancer Inst."},{"issue":"13","key":"8126_CR16","first-page":"1270","volume":"372","author":"LL Reimers","year":"2015","unstructured":"Reimers LL, Crew KD, Terry MB. Atypical hyperplasia of the breast. N Engl J Med. 2015;372(13):1270\u20131.","journal-title":"N Engl J Med."},{"issue":"1","key":"8126_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12885-017-3082-2","volume":"17","author":"RA Vierkant","year":"2017","unstructured":"Vierkant RA, Degnim AC, Radisky DC, et al. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort. BMC Cancer. 2017;17(1):84.","journal-title":"BMC Cancer."},{"issue":"2","key":"8126_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1008935821885","volume":"12","author":"C Byrne","year":"2001","unstructured":"Byrne C, Schairer C, Brinton LA, et al. Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control. 2001;12(2):103\u201310.","journal-title":"Cancer Causes Control."},{"issue":"1","key":"8126_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13058-018-1078-8","volume":"20","author":"S Hudson","year":"2018","unstructured":"Hudson S, Vik Hjerkind K, Vinnicombe S, et al. Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk. Breast Cancer Res. 2018;20(1):156.","journal-title":"Breast Cancer Res."},{"issue":"6","key":"8126_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/CEJ.0000000000000310","volume":"26","author":"L Soguel","year":"2017","unstructured":"Soguel L, Durocher F, Tchernof A, Diorio C. Adiposity, breast density, and breast cancer risk: epidemiological and biological considerations. Eur J Cancer Prev. 2017;26(6):511\u201320.","journal-title":"Eur J Cancer Prev."},{"issue":"4","key":"8126_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/aje\/kwt260","volume":"179","author":"L Baglietto","year":"2014","unstructured":"Baglietto L, Krishnan K, Stone J, et al. Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. Am J Epidemiol. 2014;179(4):475\u201383.","journal-title":"Am J Epidemiol."},{"issue":"11","key":"8126_CR22","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1158\/1055-9965.EPI-15-0330","volume":"24","author":"V Hart","year":"2015","unstructured":"Hart V, Reeves KW, Sturgeon SR, et al. The effect of change in body mass index on volumetric measures of mammographic density. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1724\u201330.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"17","key":"8126_CR23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jama.1997.03550170037029","volume":"278","author":"Z Huang","year":"1997","unstructured":"Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278(17):1407\u201311.","journal-title":"JAMA."},{"issue":"11","key":"8126_CR24","doi-asserted-by":"publisher","first-page":"e181771","DOI":"10.1001\/jamaoncol.2018.1771","volume":"4","author":"MJ Schoemaker","year":"2018","unstructured":"Schoemaker MJ, Nichols HB, Wright LB, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4(11):e181771.","journal-title":"JAMA Oncol."},{"issue":"2","key":"8126_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-013-2725-5","volume":"142","author":"TA King","year":"2013","unstructured":"King TA, Muhsen S, Patil S, et al. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 2013;142(2):445\u201353.","journal-title":"Breast Cancer Res Treat."},{"key":"8126_CR26","doi-asserted-by":"crossref","unstructured":"Vachon CM, Pankratz VS, Scott CG, et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015;107(5).","DOI":"10.1093\/jnci\/dju397"},{"key":"8126_CR27","volume-title":"Breast Imaging and Reporting and Data System (ACR BI-RADS\u00ae Atlas) teR","author":"American College of Radiology","year":"2013","unstructured":"American College of Radiology. Breast Imaging and Reporting and Data System (ACR BI-RADS\u00ae Atlas) teR, VA: American College of Radiology, 2013."},{"issue":"4","key":"8126_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.amjsurg.2006.06.015","volume":"192","author":"J Chun","year":"2006","unstructured":"Chun J, El-Tamer M, Joseph KA, Ditkoff BA, Schnabel F. Predictors of breast cancer development in a high-risk population. Am J Surg. 2006;192(4):474\u20137.","journal-title":"Am J Surg."},{"issue":"4","key":"8126_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1158\/1940-6207.CAPR-11-0482","volume":"5","author":"RS Cecchini","year":"2012","unstructured":"Cecchini RS, Costantino JP, Cauley JA, et al. Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila). 2012;5(4):583\u201392.","journal-title":"Cancer Prev Res (Phila)."},{"issue":"18","key":"8126_CR30","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90(18):1371\u201388.","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"8126_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","volume":"3","author":"VG Vogel","year":"2010","unstructured":"Vogel VG, Costantino JP, Wickerham DL, et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila). 2010;3(6):696\u2013706.","journal-title":"Cancer Prev Res (Phila)."},{"issue":"18","key":"8126_CR32","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1200\/JCO.2009.27.8077","volume":"28","author":"ME Ropka","year":"2010","unstructured":"Ropka ME, Keim J, Philbrick JT. Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol. 2010;28(18):3090\u20135.","journal-title":"J Clin Oncol."},{"issue":"1","key":"8126_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.breast.2014.11.006","volume":"24","author":"RG Roetzheim","year":"2015","unstructured":"Roetzheim RG, Lee JH, Fulp W, et al. Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast. 2015;24(1):51\u20136.","journal-title":"Breast."},{"issue":"2","key":"8126_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/tbj.13064","volume":"25","author":"CA Roche","year":"2019","unstructured":"Roche CA, Tang R, Coopey SB, Hughes KS. Chemoprevention acceptance and adherence in women with high-risk breast lesions. Breast J. 2019;25(2):190\u20135.","journal-title":"Breast J."},{"key":"8126_CR35","doi-asserted-by":"crossref","unstructured":"Flanagan MR, Zabor EC, Stempel M, Mangino DA, Morrow M, Pilewskie ML. Chemoprevention uptake for breast cancer risk reduction varies by risk factor. Ann Surg Oncol. 2019.","DOI":"10.1245\/s10434-019-07236-8"},{"key":"8126_CR36","doi-asserted-by":"crossref","unstructured":"DeCensi A PM, Guerrieri Gonzaga A, Avino F, Cortesi L, Donadio M, Pacquola M, Falcini F, Gulisano M, Digennaro M, Tienghi A, Cagossi K, Pinotti G, Varicchio C, Caviglia S, Boni L, Bonanni BEO. A randomized placebo controlled phase III trial of low dose tamoxifen for the prevention of recurrence in women with operated hormone sensitive breast ductal or lobular carcinoma in situ. San Antonio Breast Cancer Symposium. 2018;abstract GS3-01.","DOI":"10.1158\/1538-7445.SABCS18-GS3-01"},{"issue":"12","key":"8126_CR37","doi-asserted-by":"publisher","first-page":"e51446","DOI":"10.1371\/journal.pone.0051446","volume":"7","author":"Z Cheraghi","year":"2012","unstructured":"Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti Irani A. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One. 2012;7(12):e51446.","journal-title":"PLoS One."},{"issue":"3","key":"8126_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","volume":"23","author":"F Nakhlis","year":"2016","unstructured":"Nakhlis F, Gilmore L, Gelman R, et al. Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020). Ann Surg Oncol. 2016;23(3):722\u20138.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-08126-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08126-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T19:13:43Z","timestamp":1665342823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-08126-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["8126"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-08126-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"27 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All other authors have no conflict of interest disclosures to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}